Accuracy and Systematic Biases of Heart Rate Measurements by Consumer-Grade Fitness Trackers in Postoperative Patients: Prospective Clinical Trial

J Med Internet Res. 2022 Dec 30;24(12):e42359. doi: 10.2196/42359.

Abstract

Background: Over the recent years, technological advances of wrist-worn fitness trackers heralded a new era in the continuous monitoring of vital signs. So far, these devices have primarily been used for sports.

Objective: However, for using these technologies in health care, further validations of the measurement accuracy in hospitalized patients are essential but lacking to date.

Methods: We conducted a prospective validation study with 201 patients after moderate to major surgery in a controlled setting to benchmark the accuracy of heart rate measurements in 4 consumer-grade fitness trackers (Apple Watch 7, Garmin Fenix 6 Pro, Withings ScanWatch, and Fitbit Sense) against the clinical gold standard (electrocardiography).

Results: All devices exhibited high correlation (r≥0.95; P<.001) and concordance (rc≥0.94) coefficients, with a relative error as low as mean absolute percentage error <5% based on 1630 valid measurements. We identified confounders significantly biasing the measurement accuracy, although not at clinically relevant levels (mean absolute error<5 beats per minute).

Conclusions: Consumer-grade fitness trackers appear promising in hospitalized patients for monitoring heart rate.

Trial registration: ClinicalTrials.gov NCT05418881; https://www.clinicaltrials.gov/ct2/show/NCT05418881.

Keywords: Apple Watch 7; Fitbit Sense; Garmin Fenix 6 Pro; Withings ScanWatch; health tracker; internet of things; personalized medicine; photoplethysmography; smartwatch; wearable.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Electrocardiography*
  • Fitness Trackers*
  • Heart Rate / physiology
  • Humans
  • Monitoring, Physiologic
  • Patients
  • Prospective Studies

Associated data

  • ClinicalTrials.gov/NCT05418881